AAAAAA

   
Results: 1-9 |
Results: 9
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity
Authors: Forus, A D'Angelo, A Henriksen, J Merla, G Maelandsmo, GM Florenes, VA Olivieri, S Bjerkehagen, B Meza-Zepeda, LA Blanco, FD Muller, C Sanvito, F Kononen, J Nesland, JM Fodstad, O Reymond, A Kallioniemi, OP Arrigoni, G Ballabio, A Myklebost, O Zollo, M
Citation: A. Forus et al., Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity, ONCOGENE, 20(47), 2001, pp. 6881-6890
Reduced expression of p21(WAF1) is an indicator of malignant behaviour in anal carcinomas
Authors: Holm, R Skovlund, E Skomedal, H Florenes, VA Tanum, G
Citation: R. Holm et al., Reduced expression of p21(WAF1) is an indicator of malignant behaviour in anal carcinomas, HISTOPATHOL, 39(1), 2001, pp. 43-49
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications
Authors: Davidson, B Risberg, B Berner, A Nesland, JM Trope, CG Kristensen, GB Bryne, M Goscinski, M de Putte, GV Florenes, VA
Citation: B. Davidson et al., Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications, GYNECOL ONC, 83(2), 2001, pp. 249-256
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
Authors: Florenes, VA Maelandsmo, GM Faye, R Nesland, JM Holm, R
Citation: Va. Florenes et al., Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome, J PATHOLOGY, 195(5), 2001, pp. 530-536
Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
Authors: Florenes, VA Faye, RS Maelandsmo, GM Nesland, JM Holm, R
Citation: Va. Florenes et al., Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma, CLIN CANC R, 6(9), 2000, pp. 3614-3620
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
Authors: Davidson, B Berner, A Nesland, JM Risberg, B Berner, HS Trope, CG Kristensen, GB Bryne, M Florenes, VA
Citation: B. Davidson et al., E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions, J PATHOLOGY, 192(4), 2000, pp. 460-469
Interleukin-6 dependent induction of the cyclin dependent kinase inhibitorp21(WAF1/CIP1) is lost during progression of human malignant melanoma
Authors: Florenes, VA Lu, C Bhattacharya, N Rak, J Sheehan, C Slingerland, JM Kerbel, RS
Citation: Va. Florenes et al., Interleukin-6 dependent induction of the cyclin dependent kinase inhibitorp21(WAF1/CIP1) is lost during progression of human malignant melanoma, ONCOGENE, 18(4), 1999, pp. 1023-1032
Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients
Authors: Reed, W Florenes, VA Holm, R Hannisdal, E Nesland, JM
Citation: W. Reed et al., Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patients, VIRCHOWS AR, 435(2), 1999, pp. 116-124
Up-regulation of ephrin-A1 during melanoma progression
Authors: Easty, DJ Hill, SP Hsu, MY Fallowfield, ME Florenes, VA Herlyn, M Bennett, DC
Citation: Dj. Easty et al., Up-regulation of ephrin-A1 during melanoma progression, INT J CANC, 84(5), 1999, pp. 494-501
Risultati: 1-9 |